Package Label.Principal Display Panel
Mesalamine Extended-Release Capsules, 0.375 g
120 capsules
NDC 70771-1625-7
Rx only
Mfg Label (9766ebb4 1686 4e37 B139 1866e73cf182 01)
Mesalamine Capsule, Extended Release
FDA Label NDC 70771-1625
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Mesalamine (NDC 70771-1625). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
* Please review the disclaimer below.
